Cellyan Biotechnology Co Ltd Cl A

NASDAQ • Healthcare • Medical Distribution • Quote as of 10/30/2026

Company Profile

IndustryMedical Distribution

SectorHealthcare

ExchangeNASDAQ

Market Capitalization4.88 mln

Earnings Date11/30/2026

Piotroski F-Score

3 / 9

Below average

Beneish M-Score

-2.34

Borderline

Relative Strength

15 / 100

Significantly lagging

Debt / Equity

0.13

Very low leverage

Pre-Tax Margin

-8%

Marginally loss-making

ROE

-17.29

Negative

Business Description

Cellyan Biotechnology Co. Ltd, headquartered in Yau Tong, Hong Kong, helps businesses move non-prescription medicines between Hong Kong and Mainland China. Founded in 2023, the company handles procurement, storage, customs processing, and delivery, while also supporting online retail channels. Its clients include online platforms, merchants, and medicine distributors.

Key Fundamentals

EPS-1.38

ROE-17.29

RPS16.43

ROIC-14.55

ROA-10.69

Interest Cover-7.46

EBITDA, mln-0.31

EV / EBITDA-346

EV / EBIT-107

Revenue, mln13.43

EV / Revenue7.93

Quote Details

Last 1.98

Change -0.21 (-9.59%)

Open 2.12

Volume 26,924

Turnover 53,310

Average Volume 46,963

Financial Ratios

Pre-Tax Profit Margin-8

Leverage Ratio1.34

Current Ratio3.86

Price / Book5.22

Price / Tangible Book5.22

Debt / Equity0.13

Price / Sales2.76

Financial Strength

Altman Z-Score2.8

Piotroski F-Score 3 / 9

Beneish M-Score-2.34

Short Ratio0.15

Short % of Float0.59

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-1%	37 / 100
1 Month	-11.61%	27 / 100
2 Months	-76.23%	2 / 100
6 Months	-85.55%	3 / 100
1 Year	-92.67%	5 / 100